Shares of OKYO Pharma Limited (LON:OKYO – Get Free Report) fell 24.3% during mid-day trading on Friday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 364,142 shares changed hands during trading, a decline of 16% from the average session volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).
OKYO Pharma Price Performance
The firm has a market cap of £23.24 million, a PE ratio of -140.00 and a beta of -0.06. The company has a current ratio of 0.83, a quick ratio of 2.65 and a debt-to-equity ratio of 1.65. The company has a 50 day moving average price of GBX 1.40 and a 200 day moving average price of GBX 1.40.
OKYO Pharma Company Profile
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
Recommended Stories
- Five stocks we like better than OKYO Pharma
- Why Are These Companies Considered Blue Chips?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to Invest in Insurance Companies: A Guide
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What Are Some of the Best Large-Cap Stocks to Buy?
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
